Nuclear receptors and liver disease (the Part 2)

QR Code

Nuclear receptors and liver disease (the Part 2)

.

Saved in:

Bibliographic Details
Main Author:	V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2010-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Online Access:	https://www.gastro-j.ru/jour/article/view/1538
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nuclear receptors and liver disease (the Part 1)
by: V. T. Ivashkin
Published: (2010-06-01)

Nuclear receptors in regulation of bile acids transport and metabolism
by: A. F. Sheptulina, et al.
Published: (2013-10-01)

Role of Nuclear Receptors Peroxisome Proliferator-Activated Receptors (PPARs) and Liver X Receptors (LXRs) in the Human Placental Pathophysiology
by: Marceau, Geoffroy, et al.
Published: (2012)

Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis
by: Vasiliy I. Reshetnyak, et al.
Published: (2019-12-01)

Nuclear Receptors and Metabolism of Xenobiotics
by: S. N. Larina, et al.
Published: (2020-05-01)

Nuclear receptors in metabolism and diseases: Mechanistic and therapeutic insights
by: Chen-Ying Zhu, et al.
Published: (2025-08-01)

Immunological homeostasis and immune diseases of liver
by: V. T. Ivashkin
Published: (2009-06-01)

Mechanisms of immune tolerance and liver disease
by: V. T. Ivashkin
Published: (2009-03-01)

Nuclear receptors CAR and PXR as cardiometabolic regulators
by: Janne Hukkanen, et al.
Published: (2025-09-01)

Modulation of Nuclear Receptor Action and Regulation of Medicines Biotransformation
by: S. N. Larina, et al.
Published: (2020-05-01)

Liver Diseases and the Hemostasis (Rewiew) Part 1. Non-Cholestatic Diseases of the Liver and Hemostasis
by: V. I. Reshetnyak, et al.
Published: (2019-11-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Orphan Nuclear Receptors TR2 and TR4 in Erythropoiesis: From Mechanisms to Therapies
by: Yunlong Liu, et al.
Published: (2025-05-01)

The role of nuclear receptors in metabolic homeostasis and disease: From molecular mechanisms to drug discovery
by: Fangfang He, et al.
Published: (2025-08-01)

Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)

Metabolism of bile acids, liver diseases and microbiome
by: Yu. V. Yevsyutina, et al.
Published: (2018-08-01)

Treatment response rate and life prognosis at autoimmune liver diseases
by: K. V. Ivashkin, et al.
Published: (2015-10-01)

Possible Roles of Nuclear Lipids in Liver Regeneration
by: Viola-Magni, M., et al.
Published: (2012)

Gelsolin Facilitates Estrogen Receptor Beta Nuclear Translocation and Transcriptional Repression of Genes Associated with Alzheimer Disease
by: Yoldas Yildiz, et al.
Published: (2025-05-01)

Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2
by: N. G. Astafieva, et al.
Published: (2024-05-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

The effect of nuclear transcriptional factor κВ activation inhibitor – curcumine on the experimental immune liver disease
by: I. N. Alekseyeva, et al.
Published: (2010-02-01)

Principles of effective out-patient diagnostics of diffuse liver diseases
by: Komova A. G., et al.
Published: (2014-11-01)

Engineered Nuclear Hormone Receptor-Biosensors for Environmental Monitoring and Early Drug Discovery
by: Gierach, Izabela, et al.
Published: (2011)

Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
by: Xianhua Mao, et al.
Published: (2025-07-01)

Portal Vein Thrombosis in Liver Cirrhosis. Part 2: Treatment, Primary and Secondary Prevention
by: A. V. Yagoda, et al.
Published: (2024-08-01)

Alcohol-induced liver disease: primary and secondary prevention
by: S. V. Plyusnin, et al.
Published: (2015-07-01)

Modern Approaches to Vaccination of Patients with Chronic Liver Diseases and Inflammatory Bowel Diseases against a Novel Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Functional Changes Associated With the Subcellular Localization of the Nuclear Receptor NR4A1
by: Yoshimitsu Kiriyama, et al.
Published: (2025-01-01)

Nuclear localization of platelet activating factor receptor accounts for microglial phagocytosis in ischemic stroke
by: Xi-Yue Zhang, et al.
Published: (2025-09-01)

Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease
by: A. V. Morozova, et al.
Published: (2014-09-01)

Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientific Liver Society
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

CHEMOKINES AND THEIR RECEPTORS EXPRESSION IN BLOOD AND LIVER TISSUE IN CHRONIC HEPATITIS C
by: K. V. Zhdanov, et al.
Published: (2014-07-01)

Epigenetic influence of long non-coding RNAs on the development of insulin resistance in metabolically associated fatty liver disease (part 2)
by: O.E. Abaturov, et al.
Published: (2025-05-01)

PERSPECTIVES OF TREATMENT OF TERMINAL LIVER DISEASE IN CHRONIC HCV-INFECTION
by: E. N. German, et al.
Published: (2010-06-01)

Expression of bcl-2 in the liver tissue of patients with autoimmune liver diseases and chronic hepatitis C
by: K. L. Raykhel`son, et al.
Published: (2014-09-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
by: S. I. Zabroda, et al.
Published: (2015-07-01)

Drug-induced liver injuries (Part 1)
by: S. F. Galimova
Published: (2012-06-01)

EXPRESSION DENSITY OF RECEPTORS FOR IMMUNOREGULATORY MEDIATORS AS A MODULATORY COMPONENT OF BIOLOGICAL EFFECTS OF MEDIATORS UPON CELLS (PART 2)
by: S. V. Sennikov, et al.
Published: (2019-07-01)